21st Apr 2021 14:17
Ap19
FORM 8.3 Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 19 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,688,071 | 1.31% | 164,070 | 0.13% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 7,100 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,766,530 | 1.37% | 177,270 | 0.14% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 238.4675 USD |
Purchase | 3 | 238.7500 USD |
Purchase | 3 | 238.9200 USD |
Purchase | 4 | 239.3550 USD |
Purchase | 6 | 239.2600 USD |
Purchase | 8 | 238.3200 USD |
Purchase | 9 | 238.5300 USD |
Purchase | 10 | 238.9165 USD |
Purchase | 18 | 238.6583 USD |
Purchase | 18 | 238.8866 USD |
Purchase | 28 | 238.7819 USD |
Purchase | 75 | 238.2500 USD |
Purchase | 83 | 239.4700 USD |
Purchase | 100 | 239.0000 USD |
Purchase | 100 | 239.5050 USD |
Purchase | 100 | 239.4900 USD |
Purchase | 103 | 238.8700 USD |
Purchase | 269 | 240.3746 USD |
Purchase | 293 | 240.1028 USD |
Purchase | 293 | 240.1027 USD |
Purchase | 309 | 240.5839 USD |
Purchase | 385 | 238.9995 USD |
Purchase | 400 | 239.2523 USD |
Purchase | 476 | 239.2383 USD |
Purchase | 500 | 239.0473 USD |
Purchase | 833 | 238.9254 USD |
Purchase | 907 | 238.2045 USD |
Purchase | 2,474 | 238.5187 USD |
Purchase | 2,584 | 240.4000 USD |
Purchase | 2,603 | 239.4234 USD |
Purchase | 3,448 | 239.2521 USD |
Purchase | 3,641 | 238.0106 USD |
Purchase | 3,749 | 238.5805 USD |
Purchase | 6,052 | 238.9040 USD |
Purchase | 13,767 | 238.0100 USD |
Purchase | 38,699 | 238.4317 USD |
Sale | 1 | 240.1050 USD |
Sale | 1 | 239.1500 USD |
Sale | 2 | 238.8100 USD |
Sale | 3 | 239.7600 USD |
Sale | 4 | 239.9050 USD |
Sale | 4 | 239.6137 USD |
Sale | 7 | 239.1750 USD |
Sale | 7 | 239.0357 USD |
Sale | 8 | 238.3200 USD |
Sale | 10 | 238.9740 USD |
Sale | 10 | 239.3660 USD |
Sale | 12 | 239.2537 USD |
Sale | 12 | 239.2333 USD |
Sale | 17 | 238.8611 USD |
Sale | 19 | 239.0784 USD |
Sale | 19 | 238.9500 USD |
Sale | 89 | 238.8900 USD |
Sale | 100 | 239.5050 USD |
Sale | 100 | 238.9600 USD |
Sale | 124 | 238.7080 USD |
Sale | 143 | 238.9129 USD |
Sale | 200 | 238.9650 USD |
Sale | 208 | 238.8604 USD |
Sale | 244 | 238.9414 USD |
Sale | 269 | 240.3746 USD |
Sale | 293 | 240.1027 USD |
Sale | 293 | 240.1028 USD |
Sale | 300 | 238.8966 USD |
Sale | 433 | 238.9732 USD |
Sale | 490 | 239.3043 USD |
Sale | 576 | 238.8733 USD |
Sale | 587 | 239.0150 USD |
Sale | 800 | 238.0738 USD |
Sale | 993 | 240.3160 USD |
Sale | 1,049 | 238.9942 USD |
Sale | 1,695 | 239.4362 USD |
Sale | 2,021 | 238.1858 USD |
Sale | 2,584 | 240.4000 USD |
Sale | 3,643 | 238.0109 USD |
Sale | 5,002 | 238.8848 USD |
Sale | 5,656 | 238.9221 USD |
Sale | 5,953 | 238.0101 USD |
Sale | 7,083 | 238.0100 USD |
Sale | 40,527 | 238.4622 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 21 Apr 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210421005645/en/
Copyright Business Wire 2021
Related Shares:
Barclays